Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04057716 · ClinicalTrials.gov registry record · NA

Project REST: Regulation of Eating and Sleep Topography

A NA study of Sleep and Obesity, Childhood, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT04057716: Recruiting NA study of Sleep and Obesity, Childhood, sponsored by University of Pittsburgh.

NCT04057716 is a NA study of Sleep and Obesity, Childhood that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 120 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04057716, a NA study of Sleep and Obesity, Childhood, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

Overweight/obesity and inadequate sleep are prevalent, and frequently co-occurring, health risks among children, both of which are associated with serious medical and psychosocial health complications including risk for cardiovascular disease. Although the investigator's data suggest that disrupted or shortened sleep may be causally associated with increased energy intake and weight gain in children, and with self-regulation and neural response to food cues in adults, understanding of mechanisms involved in the sleep/eating association is incomplete, thereby impeding development of targeted, optimally timed intervention strategies. The proposed mechanistic clinical trial aims to assess the effects of an experimental sleep manipulation on eating-related self-regulation and its neural substrates, and on real-world eating behavior, among children with overweight/obesity, which will help guide research efforts towards the refinement of prevention and intervention strategies targeting sleep and its eating-related correlates to curb weight gain throughout development.

Primary Outcome

BMI (body mass index)

Interventions

  • BEHAVIORAL Sleep restriction
  • BEHAVIORAL Sleep extension

Study Locations (2)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Rhode Island

  • Weight Control & Diabetes Research Center - Providence

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2019-08-15
Est. Completion 2026-05-29
Phase NA
University of Pittsburgh

1,238 total trials

What NCT04057716 shows while recruiting

NCT04057716 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower).

The record links to 4 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Sleep restriction is the first listed.

NCT04057716 reports a single indexed study location in Pennsylvania, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT04057716 about?

NCT04057716 is a clinical study titled "Project REST: Regulation of Eating and Sleep Topography". Overweight/obesity and inadequate sleep are prevalent, and frequently co-occurring, health risks among children, both of which are associated with serious medical and psychosocial health complications including risk for cardiovascular disease. Although the investigator's data suggest that disrupted ...

What is the current status of trial NCT04057716?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2019-08-15. Estimated completion is 2026-05-29.

What conditions does trial NCT04057716 study?

This clinical trial studies the following conditions: Sleep, Obesity, Childhood, Binge Eating, Self-regulation.

What interventions are being tested in trial NCT04057716?

The interventions under investigation include: Sleep restriction (BEHAVIORAL), Sleep extension (BEHAVIORAL).

Who is sponsoring clinical trial NCT04057716?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04057716 being conducted?

This trial has 2 study locations across Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04057716's enrollment target sits among peer trials

120 47th of 151 higher than 101 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04057716, the US trial registry maintained by the National Library of Medicine. NCT04057716 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.